ArticleCancer2021

Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).

Kristy Kummerow Broman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.